vs
HANMI FINANCIAL CORP（HAFC）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是HANMI FINANCIAL CORP的1.1倍（$75.5M vs $71.2M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 17.1%），HANMI FINANCIAL CORP自由现金流更多（$203.7M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 10.4%）
韩美金融（HANMI FINANCIAL CORP）旗下韩美银行是一家总部位于美国加利福尼亚州洛杉矶的社区银行，目前在加州、得州、伊利诺伊州、纽约州、新泽西州和弗吉尼亚州共设有35家分行与8个贷款业务办事处。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
HAFC vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.1倍
$71.2M
营收增速更快
PBYI
高出10.7%
17.1%
自由现金流更多
HAFC
多$189.3M
$14.4M
两年增速更快
PBYI
近两年复合增速
10.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $71.2M | $75.5M |
| 净利润 | $21.2M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 29.8% | 22.7% |
| 净利率 | 29.8% | — |
| 营收同比 | 17.1% | 27.7% |
| 净利润同比 | 20.0% | — |
| 每股收益（稀释后） | $0.70 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HAFCPBYI
| Q4 25 | $71.2M | $75.5M | ||
| Q3 25 | $71.0M | $54.5M | ||
| Q2 25 | $65.2M | $52.4M | ||
| Q1 25 | $62.8M | $46.0M | ||
| Q4 24 | $60.8M | $59.1M | ||
| Q3 24 | $58.5M | $80.5M | ||
| Q2 24 | $56.7M | $47.1M | ||
| Q1 24 | $58.4M | $43.8M |
净利润HAFCPBYI
| Q4 25 | $21.2M | — | ||
| Q3 25 | $22.1M | $8.8M | ||
| Q2 25 | $15.1M | $5.9M | ||
| Q1 25 | $17.7M | $3.0M | ||
| Q4 24 | $17.7M | — | ||
| Q3 24 | $14.9M | $20.3M | ||
| Q2 24 | $14.5M | $-4.5M | ||
| Q1 24 | $15.2M | $-4.8M |
毛利率HAFCPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率HAFCPBYI
| Q4 25 | 29.8% | 22.7% | ||
| Q3 25 | 31.1% | 17.6% | ||
| Q2 25 | 23.2% | 12.7% | ||
| Q1 25 | 28.1% | 8.7% | ||
| Q4 24 | 29.1% | 22.6% | ||
| Q3 24 | 25.5% | 27.4% | ||
| Q2 24 | 25.5% | -4.6% | ||
| Q1 24 | 26.0% | -5.3% |
净利率HAFCPBYI
| Q4 25 | 29.8% | — | ||
| Q3 25 | 31.1% | 16.2% | ||
| Q2 25 | 23.2% | 11.2% | ||
| Q1 25 | 28.1% | 6.5% | ||
| Q4 24 | 29.1% | — | ||
| Q3 24 | 25.5% | 25.2% | ||
| Q2 24 | 25.5% | -9.6% | ||
| Q1 24 | 26.0% | -11.0% |
每股收益（稀释后）HAFCPBYI
| Q4 25 | $0.70 | $0.26 | ||
| Q3 25 | $0.73 | $0.17 | ||
| Q2 25 | $0.50 | $0.12 | ||
| Q1 25 | $0.58 | $0.06 | ||
| Q4 24 | $0.58 | $0.40 | ||
| Q3 24 | $0.49 | $0.41 | ||
| Q2 24 | $0.48 | $-0.09 | ||
| Q1 24 | $0.50 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $796.4M | $130.3M |
| 总资产 | $7.9B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资HAFCPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务HAFCPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益HAFCPBYI
| Q4 25 | $796.4M | $130.3M | ||
| Q3 25 | $779.5M | $115.3M | ||
| Q2 25 | $762.8M | $104.7M | ||
| Q1 25 | $751.5M | $97.1M | ||
| Q4 24 | $732.2M | $92.1M | ||
| Q3 24 | $736.7M | $71.1M | ||
| Q2 24 | $707.1M | $48.5M | ||
| Q1 24 | $703.1M | $51.0M |
总资产HAFCPBYI
| Q4 25 | $7.9B | $216.3M | ||
| Q3 25 | $7.9B | $202.9M | ||
| Q2 25 | $7.9B | $194.9M | ||
| Q1 25 | $7.7B | $196.2M | ||
| Q4 24 | $7.7B | $213.3M | ||
| Q3 24 | $7.7B | $220.7M | ||
| Q2 24 | $7.6B | $205.0M | ||
| Q1 24 | $7.5B | $214.1M |
负债/权益比HAFCPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $206.0M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $203.7M | $14.4M |
| 自由现金流率自由现金流/营收 | 286.2% | 19.1% |
| 资本支出强度资本支出/营收 | 3.2% | 0.0% |
| 现金转化率经营现金流/净利润 | 9.70× | — |
| 过去12个月自由现金流最近4个季度 | $356.1M | $41.7M |
8季度趋势，按日历期对齐
经营现金流HAFCPBYI
| Q4 25 | $206.0M | $14.4M | ||
| Q3 25 | $146.9M | $9.7M | ||
| Q2 25 | $-19.0M | $14.1M | ||
| Q1 25 | $25.8M | $3.6M | ||
| Q4 24 | $52.6M | $15.6M | ||
| Q3 24 | $6.7M | $11.0M | ||
| Q2 24 | $2.1M | $1.0M | ||
| Q1 24 | $30.0M | $11.2M |
自由现金流HAFCPBYI
| Q4 25 | $203.7M | $14.4M | ||
| Q3 25 | $146.4M | $9.7M | ||
| Q2 25 | $-19.6M | $14.1M | ||
| Q1 25 | $25.6M | $3.6M | ||
| Q4 24 | $49.9M | $15.6M | ||
| Q3 24 | $6.5M | $11.0M | ||
| Q2 24 | $1.3M | $1.0M | ||
| Q1 24 | $29.2M | — |
自由现金流率HAFCPBYI
| Q4 25 | 286.2% | 19.1% | ||
| Q3 25 | 206.3% | 17.7% | ||
| Q2 25 | -30.0% | 26.8% | ||
| Q1 25 | 40.7% | 7.7% | ||
| Q4 24 | 82.1% | 26.4% | ||
| Q3 24 | 11.1% | 13.7% | ||
| Q2 24 | 2.3% | 2.1% | ||
| Q1 24 | 50.0% | — |
资本支出强度HAFCPBYI
| Q4 25 | 3.2% | 0.0% | ||
| Q3 25 | 0.8% | 0.0% | ||
| Q2 25 | 0.9% | 0.0% | ||
| Q1 25 | 0.4% | 0.1% | ||
| Q4 24 | 4.3% | 0.0% | ||
| Q3 24 | 0.4% | 0.0% | ||
| Q2 24 | 1.4% | 0.0% | ||
| Q1 24 | 1.4% | 0.0% |
现金转化率HAFCPBYI
| Q4 25 | 9.70× | — | ||
| Q3 25 | 6.66× | 1.10× | ||
| Q2 25 | -1.26× | 2.41× | ||
| Q1 25 | 1.46× | 1.21× | ||
| Q4 24 | 2.97× | — | ||
| Q3 24 | 0.45× | 0.54× | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 1.98× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
